MedTrace Logo

Alcohol, Inflammation and Atherosclerosis

NCT00764426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2008-10-02

No results posted yet for this study

Summary

Effect of moderate alcohol consumption in form of red wine, beer and ethanol solution and corresponding de-alcoholised beverages on immune measures.

* In healthy middle aged men and women
* In a randomized controlled cross-over trial
* Two intervention periods over 3 weeks

Conditions

Interventions

DRUG

red wine, beer, ethanol

Alcoholic beverages equivalent to 30g of alcohol per day for men and 20g/d for women for 3 weeks

DRUG

de-alcoholised red wine, de-alcoholised beer, water

de-alcoholised red wine, de-alcoholised beer, water

Sponsors & Collaborators

  • European Research Advisory Board

    lead OTHER

Principal Investigators

  • Armin P Imhof, MD · University of Ulm, Medical Center, Ulm, Germany

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00764426 on ClinicalTrials.gov